Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
JCSE 01 - Joint IASLC/CSCO/CAALC Session: Immunotherapy for Management of Lung Cancer: Ongoing Research from East and West
- 07:30 - 11:30
- 10/15/2017
- Location: F203 (Annex Hall)
- Type: Joint Session IASLC/CSCO/CAALC
- Track: Immunology and Immunotherapy
- Moderators:C. Bai, Fred R. Hirsch, Tony SK Mok, Yi-Long Wu
-
+
JCSE 01.23 - The Feasibility of Osimertinib Treatment on Brain Metastases in NSCLC Patients After 1st Generation EGFR-TKI Resistance: A Preliminary Study
11:30 - 11:30 | Presenter: Lucheng Zhu | Author(s): S. Zhang, B. Xia, X. Chen, S. Ma
- Abstract
Loading...
-
+
P1.01 - Advanced NSCLC
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Advanced NSCLC
-
+
P1.01-036 - Identifying and Addressing Gaps in Molecular Testing for Patients with Lung Cancer
09:30 - 09:30 | Presenter: Jennifer C King | Author(s): A. Ciupek, T. Perloff, A. Blanchard, K. Mason, E. Blais, D. Halverson, J. Bender, S. Madhavan, E. Petricoin
- Abstract
Loading... -
+
P1.01-041 - Role of Re-Biopsy During Disease Progression Non-Small Cell Lung Cancer for Acquired Resistance Analysis and Directing Oncology Treatments
09:30 - 09:30 | Presenter: Masatoshi Kakihana | Author(s): J. Maeda, J. Matsubayashi, S. Maehara, M. Hagiwara, T. Okano, Naohiro Kajiwara, T. Ohira, T. Nagao, Norihiko Ikeda
- Abstract
Loading...
-
+
P1.02 - Biology/Pathology
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Biology/Pathology
-
+
P1.02-002 - Diagnostic Utility of MUC4 Expression to Differentiate Epithelioid Mesothelioma from Lung Adenocarcinoma and Squamous Cell Carcinoma
09:30 - 09:30 | Presenter: Vishwa Jeet Amatya | Author(s): A.S. Mawas, Kei Kushitani, Y. Kai, Y. Miyata, Morihito Okada, Y. Takeshima
- Abstract
Loading... -
+
P1.02-018 - Number of Cancer Cells in Lung Adenocarcinoma Specimen – Correlation with Noguchi's Classification, WHO Pathologic Type, and Prognosis
09:30 - 09:30 | Presenter: Takashi Inoue | Author(s): Y. Nakazato, M. Nishihira, O. Araki, Y. Karube, S. Maeda, S. Kobayashi, M. Chida
- Abstract
Loading... -
+
P1.02-052 - Identification of DAB2 and Intelectin-1 as Novel Positive Immunohistochemical Markers of Epithelioid Mesothelioma
09:30 - 09:30 | Presenter: Masatsugu Kuraoka | Author(s): Vishwa Jeet Amatya, Kei Kushitani, A.S. Mawas, Y. Miyata, Morihito Okada, T. Kishimoto, K. Inai, T. Nishisaka, T. Sueda, Y. Takeshima
- Abstract
Loading...
-
+
P1.03 - Chemotherapy/Targeted Therapy
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Chemotherapy/Targeted Therapy
-
+
P1.03-005 - Phase 2 Study of Ceritinib in Patients with ALK+ NSCLC with Prior Alectinib Treatment in Japan: ASCEND-9
09:30 - 09:30 | Presenter: Hidehito Horinouchi | Author(s): M. Maemondo, T. Hida, M. Takeda, K. Hotta, F. Hirai, Y.H. Kim, S. Matsumoto, Tetsuya Mitsudomi, Takashi Seto, S. Moizumi, K. Tokushige, B. Hatano, Makoto Nishio
- Abstract
Loading... -
+
P1.03-009 - A Lung Adenocarcinoma with a STRN-ALK Rearrangement Was Poorly Responsive to Alectinib Treatment
09:30 - 09:30 | Presenter: Yuko Iida | Author(s): Yoko Nakanishi, N. Takahashi, H. Nishimaki, T. Nishizawa, Yoshiko Nakagawa, T. Shimizu, Y. Gon, S. Masuda, S. Hashimoto
- Abstract
Loading...
-
+
P1.07 - Immunology and Immunotherapy
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Immunology and Immunotherapy
-
+
P1.07-015 - Interferon-Gamma (INFG) as a Biomarker to Guide Immune Checkpoint Blockade (ICB) in Cancer Therapy
09:30 - 09:30 | Presenter: Niki Karachaliou | Author(s): M. González Cao, A. Giménez-Capitán, A. Drozdowskyj, E. Aldeguer, C. Teixido, G. Crespo, Miguel-Angel Molina-Vila, S. Viteri, M. De Los Llanos Gil, S. Martín Algarra, E. Pérez-Ruiz, I. Márquez-Rodas, D. Rodríguez-Abreu, R. Blanco, T. Puértolas, M.A. Royo, Rafael Rosell
- Abstract
Loading...
-
+
P1.09 - Mesothelioma
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Mesothelioma
-
+
P1.09-012 - A Pre-Clinical Investigation of Intrapleural Curcumin Treatments as an Adjunct Therapy for Malignant Pleural Mesothelioma
09:30 - 09:30 | Presenter: Ashleigh Jean Hocking | Author(s): D. Elliot, J. Hua, M. Michael, S. Marri, Sonja Klebe
- Abstract
Loading...
-
+
P1.16 - Surgery
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Surgery
-
+
P1.16-010 - Development of a Novel Surgical Marking Method Using Low Power Laser Light
09:30 - 09:30 | Presenter: Keishi Ohtani | Author(s): S. Maehara, K. Imai, H. Furumoto, M. Hagiwara, T. Okano, Masatoshi Kakihana, Naohiro Kajiwara, T. Ohira, Norihiko Ikeda
- Abstract
Loading...
-
+
MS 01 - Clinical Development of Novel Agents
- 11:00 - 12:30
- 10/16/2017
- Location: Main Hall
- Type: Mini Symposium
- Track: Clinical Design, Statistics and Clinical Trials
- Moderators:S. Mandrekar, M. Mori
-
+
MS 01.01 - Expansion Cohorts in Phase I Trials: Non Controlled Phase II or Translational Science?
11:00 - 11:20 | Presenter: Benjamin Besse
- Abstract
No abstract available for this presentation
-
+
MS 01.02 - Are We Categorizing Biomarkers Too Quickly?
11:20 - 11:40 | Presenter: Jack Lee
- Abstract
No abstract available for this presentation
-
+
MS 01.03 - Innovative Trial Designs: What is the Minimal Burden of Proof for Drug Approval?
11:40 - 12:00 | Presenter: Giuseppe Giaccone
- Abstract
No abstract available for this presentation
-
+
MS 01.04 - Is "Big Data" the Solution to the Complex Therapeutic Landscape?
12:00 - 12:20 | Presenter: Yu Shyr
- Abstract
Loading... -
+
MS 01.05 - Q&A
12:20 - 12:30
- Abstract
No abstract available for this presentation
-
+
P2.01 - Advanced NSCLC
- 09:00 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Advanced NSCLC
-
+
P2.01-054 - Inclusion of Central Nervous System Metastasis in Lung Cancer Early Phase Clinical Trials
09:00 - 09:00 | Presenter: Narjust Duma | Author(s): M. Gonzalez Velez, V. Mariotti, R. Carr, Erin Schenk, K. Leventakos, J. Molina, Aaron S. Mansfield, Alex Adjei
- Abstract
Loading...
-
+
P2.02 - Biology/Pathology
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Biology/Pathology
-
+
P2.02-009 - Metabolomic Analysis in Lung Cancer
09:30 - 09:30 | Presenter: Naohiro Kajiwara | Author(s): S. Maehara, J. Maeda, M. Hagiwara, T. Okano, Masatoshi Kakihana, Tatsuo Ohira, M. Sugimoto, Norihiko Ikeda
- Abstract
Loading... -
+
P2.02-057 - Expression of MGAT4a and MGAT5 Are Correlated with Poorer Outcome in Advanced Lung Adenocarcinoma
09:30 - 09:30 | Presenter: Yoko Nakanishi | Author(s): H. Nishimaki, I. Tsujino, N. Takahashi, M. Shimamura, H. Kobayashi, X.Y. Tang, Y. Kusumi, S. Hashimoto, S. Masuda
- Abstract
Loading...